Clinicians advised to halt use of propofol from tainted lots

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Clinicians advised to halt use of propofol from tainted lots

Published Date:

7/9/09

Series:

HAN ; 296

Language:

English

[PDF-505.03 KB]

Details:

Corporate Authors:

Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration. ;

Description:

Monday, July 13, 2009, 19:00 EDT (7:00 PM EDT) CDCHAN-00296-2009-07-13-ADV-N The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) have been investigating recent cases of febrile reactions among patients undergoing endoscopy in the United States. This investigation has revealed that all of the case-patients received the anesthetic propofol from 100 ml vials manufactured byTeva Pharmaceuticals. Testing done by the FDA has found that two lots of this product that were in use in facilities reporting febrile reactions were positive for elevated levels of endotoxin. The lots are 31305429B and 31305430B. Teva Pharmaceuticals is initiating a voluntary recall for these lots, and clinicians are advised to immediately stop using these lots of Teva Pharmaceuticals propofol. CDC, FDA and Teva Pharmaceuticals are continuing to investigate this issue.

Subject:

[+]

Document Type:

HAN Health Advisory

Place as Subject:

United States

Collection(s):

Health Alert Network (HAN)

Main Document Checksum:

[+]

Supporting Files:

No Additional Files

No Related Documents.

You May Also Like:

Impact of occupational exposure on human microbiota

Personal Author:

Lai, Peggy S.; Christiani, David C.;

Published Date:

April 2019

Source:

Curr Opin Allergy Clin Immunol. 19(2):86-91

Description:

Purpose of reviewRecent evidence suggests that environmental exposures change the adult human microbiome. Here we review recent evidence on the impact of the work microbiome and work-related chemical, metal, and particulate exposures on the human mic...

File Type:

[PDF - 67.79 KB]
U.S. Compounding Pharmacy-related Outbreaks, 2001–2013—Public Health and Patient Safety Lessons Learned

Personal Author:

Shehab, Nadine; Brown, Megan N.; Kallen, Alexander J.; Perz, Joseph F.;

Published Date:

September 2018

Source:

J Patient Saf. 14(3):164-173

Description:

ObjectivesPharmacy-compounded sterile preparations (P-CSPs) are frequently relied upon in U.S. healthcare, but are increasingly being linked to outbreaks of infections. We provide an updated overview of outbreak burden and characteristics, identify d...

File Type:

[PDF - 131.12 KB]
A multistate investigation of healthcare-associated Burkholderia cepacia complex infections related to liquid docusate sodium contamination, January - October 2016.

Personal Author:

Glowicz, Janet; Crist, Matthew; Gould, Carolyn; Moulton-Meissner, Heather; Noble-Wang, Judith; de Man, Tom J. B.; Perry, K. Allison; Miller, Zachary; Yang, William C.; Langille, Stephen; Ross, Jessica; Garcia, Bobbiejean; Kim, Janice; Epson, Erin; Black, Stephanie; Pacilli, Massimo; LiPuma, John J.; Fagan, Ryan;

Corporate Authors:

and the B. cepacia investigation workgroup

Published Date:

January 09 2018

Source:

Am J Infect Control. 46(6):649-655

Description:

Outbreaks of health care-associated infections (HAIs) caused by Burkholderia cepacia complex (Bcc) have been associated with medical devices and water-based products. Water is the most common raw ingredient in nonsterile liquid drugs, and the signifi...

File Type:

[PDF - 418.37 KB]
New Parvovirus Associated with Serum Hepatitis in Horses after Inoculation of Common Biological Product

Personal Author:

Divers, Thomas J.; Tennant, Bud C.; Kumar, Arvind; McDonough, Sean; Cullen, John; Bhuva, Nishit; Jain, Komal; Chauhan, Lokendra Singh; Scheel, Troels Kasper Høyer; Lipkin, W. Ian; Laverack, Melissa; Trivedi, Sheetal; Srinivasa, Satyapramod; Beard, Laurie; Rice, Charles M.; Burbelo, Peter D.; Renshaw, Randall W.; Dubovi, Edward; Kapoor, Amit;

Published Date:

Feb 2018

Source:

Emerg Infect Dis. 24(2):303-310.

Description:

Equine serum hepatitis (i.e., Theiler's disease) is a serious and often life-threatening disease of unknown etiology that affects horses. A horse in Nebraska, USA, with serum hepatitis died 65 days after treatment with equine-origin tetanus antitoxin...

File Type:

[PDF - 2.00 MB]
Performance of Prototype High-Flow Inhalable Dust Sampler in a Livestock Production Facility

Personal Author:

Anthony, T. Renée; Cai, Changjie; Mehaffy, John; Sleeth, Darrah; Volckens, John;

Published Date:

May 2017

Source:

J Occup Environ Hyg. 14(5):313-322.

Description:

A high-flow inhalable sampler, designed for operational flow rates up to 10 L/min using computer simulations and examined in wind tunnel experiments, was evaluated in the field. This prototype sampler was deployed in collocation with an IOM (the benc...

File Type:

[PDF - 880.59 KB]